David Blumenthal on Big Changes to the ACA and the Challenges of Personalized Medicine

In two new Wall Street Journal “Experts” blog posts, Commonwealth Fund President David Blumenthal, M.D., addresses two issues on the health policy horizon. The first post considers how to manage the high costs and ethical questions that come with precision treatments. The second examines the potential impact of waivers taking effect in 2017 that will allow states to change how coverage is provided to the uninsured, including by replacing the insurance marketplaces.